Article
The Potential of Janus Kinase Inhibitors for Rheumatoid Arthritis, Psoriatic Arthritis, Colitis
Rating:
0.0
Views:
128
Likes:
1
Library:
1
A review of new oral JAK inhibitor medications for the treatment of refractory rheumatoid arthritis and psoriatic arthritis, including tofacitinib (Xeljanz, Pfizer), baricitinib (Olumiant, Lilly), upadacitinib (Rinvoq, AbbVie), and filgotinib (GLPG0634, Gilead).
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value